Drug General Information
Drug ID
D08LQA
Former ID
DNC000142
Drug Name
Accutin
Drug Type
Small molecular drug
Indication Discovery agent Investigative [538134]
Structure
Download
2D MOL

3D MOL

Formula
C6H6O2
Canonical SMILES
C1=CC(=CC=C1O)O
InChI
1S/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8H
InChIKey
QIGBRXMKCJKVMJ-UHFFFAOYSA-N
CAS Number
CAS 123-31-9
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:17594
SuperDrug ATC ID
D11AX11
SuperDrug CAS ID
cas=000123319
Target and Pathway
Target(s) Glycoprotein IIb/IIIa receptor Target Info Antagonist [538134]
Reactome Platelet degranulation
Elastic fibre formation
PECAM1 interactions
Molecules associated with elastic fibres
Integrin cell surface interactions
Syndecan interactions
ECM proteoglycans
Integrin alphaIIb beta3 signaling
GRB2:SOS provides linkage to MAPK signaling for Integrins
p130Cas linkage to MAPK signaling for integrins
VEGFA-VEGFR2 Pathway
MAP2K and MAPK activation
WikiPathways Focal Adhesion
Hematopoietic Stem Cell Differentiation
Human Complement System
Extracellular matrix organization
Arrhythmogenic Right Ventricular Cardiomyopathy
Integrin-mediated Cell Adhesion
L1CAM interactions
Integrin cell surface interactions
Integrin alphaIIb beta3 signaling
References
Ref 538134Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis. Blood. 1998 Nov 1;92(9):3268-76.
Ref 538134Accutin, a new disintegrin, inhibits angiogenesis in vitro and in vivo by acting as integrin alphavbeta3 antagonist and inducing apoptosis. Blood. 1998 Nov 1;92(9):3268-76.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.